Drug News
-
FDA Class I Recall Alert: Cordis INFINITI Angiographic Catheter
Recalled Product Information: Product Names: Cordis INFINITI Angiographic Catheter Product Codes: DQO Lot Number: 18223410 Distribution Dates: August 21, 2023,…
Read More » -
PrecisePK Pioneers Model-Informed Precision Dosing and Pharmacokinetics Advancements in Argentina with Maza University
In a groundbreaking announcement today, PrecisePK solidifies an unprecedented partnership with Maza University, a monumental step in the realm of…
Read More » -
Amplity Health Unveils AI-Driven Survey Platform, Revolutionizing Early Drug Launch Insights
In a groundbreaking move, Contract Medical and Commercial Organization, Amplity Health, has introduced a pioneering AI-driven solution named Survey by…
Read More » -
Supreme Court Considers Purdue Pharma Case, Balancing Legal Protections and Due Process
In a pivotal legal battle, the U.S. Supreme Court grapples with the Purdue Pharma case, navigating a delicate balance between…
Read More » -
Merck KGaA Faces Significant Setback as Multiple Sclerosis Drug Falters in Advanced Trials
Merck KGaA’s (MRCG.DE) growth ambitions have taken a significant hit as its experimental multiple sclerosis (MS) drug, evobrutinib, fell short…
Read More » -
Leal Health Leverages Generative AI to Optimize Cancer Treatment Matching for Patients
Leal Health, formerly known as Trialjectory, has unveiled a groundbreaking addition to its patient-centric, AI-powered treatment platform for cancer care.…
Read More » -
Global Acute Myeloid Leukemia (AML) Therapeutics Market Projected to Reach $1.6 Billion by 2030
The “Acute Myeloid Leukemia (AML) Therapeutics – Global Strategic Business Report” by ResearchAndMarkets.com reveals a robust growth projection for the…
Read More » -
ASOP Survey Reveals More Americans Buy Meds Online Despite Safety Risks
A recent survey commissioned by the Alliance for Safe Online Pharmacies (ASOP) Global Foundation highlights a significant increase in Americans…
Read More » -
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8%
Qilu Pharmaceutical presented the latest results of the single-arm, phase II pivotal clinical study for iparomlimab (QL1604), an innovative Class…
Read More » -
FDA Announces The Voluntary Recall of SoClean Equipment Intended for Use with CPAP Devices and Accessories
The U.S. Food and Drug Administration (FDA) is providing additional information about a product recall related to the use of…
Read More »